SUSTAINED VIROLOGIC RESPONSE AMONG PATIENTS WITH GENOTYPE 1 HEPATITIS C AND TREATED WITH INTERFERON-FREE DIRECT-ACTING ANTIVIRAL REGIMENS

被引：0
|
作者：
Hull, M. [1 ]
Puenpatom, A. [2 ]
McPheeters, J. [1 ]
Schwebke, K. [1 ]
机构：
[1] OPTUM, Eden Prairie, MN USA
[2] Merck & Co Inc, Kenilworth, NJ USA
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01557-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-217
引用
收藏
页码：S798 / S798
页数：1
相关论文
共 50 条
  • [21] Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies
    John B. Dever
    Julie H. Ducom
    Ariel Ma
    Joseph Nguyen
    Lin Liu
    Ann Herrin
    Erik J. Groessl
    Samuel B. Ho
    Digestive Diseases and Sciences, 2017, 62 : 1472 - 1479
  • [22] Revisiting the Predictors of a Sustained Virologic Response in the Era of Direct-Acting Antiviral Therapy for Hepatitis C Virus
    Beinhardt, Sandra
    Rutter, Karoline
    Staettermayer, Albert Friedrich
    Ferenci, Peter
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (01) : 118 - 122
  • [23] What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
    Ioannou, George N.
    Feld, Jordan J.
    GASTROENTEROLOGY, 2019, 156 (02) : 446 - +
  • [24] Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia
    Ji, F.
    Wei, B.
    Yeo, Y. H.
    Ogawa, E.
    Zou, B.
    Stave, C. D.
    Li, Z.
    Dang, S.
    Furusyo, N.
    Cheung, R. C.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 550 - 562
  • [25] Hepatitis C virus direct-acting antiviral nonadherence: Relationship to sustained virologic response and identification of at-risk patients
    Slevin, Amber R.
    Hart, Mickey J.
    Van Horn, Caroline
    Rahman, Syed
    Samji, Naga Swetha
    Szabo, Aniko
    Rein, Lisa
    Werner, Shannon
    Saeian, Kia
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2019, 59 (01) : 51 - 56
  • [26] Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014-2018)
    Gordon, Stuart C.
    Teshale, Eyasu H.
    Spradling, Philip R.
    Moorman, Anne C.
    Boscarino, Joseph A.
    Schmidt, Mark A.
    Daida, Yihe G.
    Rupp, Loralee B.
    Trudeau, Sheri
    Zhang, Jiaqi
    Lu, Mei
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (08) : 1453 - 1456
  • [27] Prevalence and risk factors of hepatitis B virus reactivation in interferon-free direct-acting antiviral therapies for hepatitis C
    Kawagishi, N.
    Suda, G.
    Onozawa, M.
    Kimura, M.
    Maehara, O.
    Ohara, M.
    Izumi, T.
    Umemura, M.
    Ito, J.
    Nakai, M.
    Sho, T.
    Natsuizka, M.
    Morikawa, K.
    Ogawa, K.
    Sakamoto, N.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S725 - S726
  • [28] Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
    Liu, Chen-Hua
    Liu, Chun-Jen
    Su, Tung-Hung
    Fang, Yu-Jen
    Yang, Hung-Chih
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [29] Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals
    Fayed, Ahmed
    Hegazy, Mohamed Tharwat
    Biard, Lucie
    Vieira, Matheus
    El Shabony, Tarek
    Saadoun, David
    Casato, Milvia
    Visentini, Marcella
    Ragab, Gaafar
    Cacoub, Patrice
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (04): : 627 - 636
  • [30] Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case
    Deuffic-Burban, S.
    Obach, D.
    Canva, V.
    Pol, S.
    Roudot-Thoraval, F.
    Dhumeaux, D.
    Mathurin, P.
    Yazdanpanah, Y.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (10) : 767 - 779
12345